Caroline Schuerger is a Research Fellow at Georgetown’s Center for Security and Emerging Technology (CSET), where she focuses on emerging issues in biotechnology and AI. Prior to joining CSET, Caroline earned her PhD in Molecular Medicine at the Cleveland Clinic Lerner College of Medicine and Case Western Reserve University School of Medicine. She was a 2020 Christine Mirzayan Science and Technology Policy Fellow at the National Academies of Sciences, Engineering, and Medicine. She has earned Bachelor degrees in Biology and Chemistry from the University of North Carolina Chapel Hill.
CSET's Dr. Caroline Schuerger, Dr. Steph Batalis, and Vikram Venkatram submitted this comment with recommendations for the National Biotechnology and Biomanufacturing Initiative.
Biosafety Level-3 laboratories (BSL-3) are an essential part of research infrastructure and are used to develop vaccines and therapies. The research conducted in them provides insights into host-pathogen interactions that may help prevent future pandemics. However, these facilities also potentially pose a risk to society through lab accidents or misuse. Despite their importance, there is no comprehensive list of BSL-3 facilities, or the institutions in which they are housed. By systematically assessing PubMed articles published in English from 2006-2021, this paper maps institutions that host BSL-3 labs by their locations, augmenting current knowledge of where high-containment research is conducted globally.
CSET Research Fellow Caroline Schuerger testified before the Bipartisan Commission on Biodefense hearing on "The Biological Threat Expanse" Current and Future Challenges to National Biodefense." She discussed threats to the bioeconomy and steps the U.S. and its allies can take to harness biotechnology's capabilities and raise awareness of risky research.